title: Influence of escalating alternative reinforcer values on cigarette choice.
abstract: The availability of alternative reinforcers reduces drug taking. Escalating alternative reinforcer values have been used to initiate and maintain abstinence from drug use. A reset in reinforcer value has been added to the schedule of alternative reinforcer presentation to discourage relapse. The purpose of this preliminary study was to test the influence of escalating and escalating and resetting alternative reinforcer value on cigarette choice in the human laboratory. Fourteen daily cigarette smokers completed this experiment, which required one practice and three experimental sessions. During each experimental session, subjects made six choices between smoking a cigarette and receiving money, available under Constant, Escalating or Escalating and Resetting conditions. The total number of cigarettes chosen and puffs taken, but not the maximum consecutive number of cigarettes choices, was decreased in the Escalating condition relative to the Constant condition. The maximum number of consecutive cigarettes chosen was decreased in the Escalating and Resetting condition relative to the Constant condition. The proportion of money earned was increased in the Escalating condition relative to the Constant and Escalating and Resetting conditions. These initial findings indicate that whereas an escalating alternative reinforcer schedule reduces cigarette smoking overall, an escalating and resetting alternative reinforcer schedule may reduce repeated cigarette smoking (i.e., relapse).
authors: Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, KY 40536-0086, USA. william.stoops@uky.edu
authors: William W
authors: WW
authors: Stoops
authors: Mégan M
authors: MM
authors: Poole
authors: Andrea R
authors: AR
authors: Vansickel
authors: Craig R
authors: CR
authors: Rush
references: Nicotine Tob Res. 2001 Feb;3(1):7-16
references: 11260806
references: Drug Alcohol Depend. 2009 Nov 1;105(1-2):56-62
references: 19615830
references: Hum Psychopharmacol. 2007 Jan;22(1):41-7
references: 17149785
references: Am J Psychiatry. 2006 Nov;163(11):1993-9
references: 17074952
references: Am J Psychiatry. 1991 Sep;148(9):1218-24
references: 1883001
references: Psychopharmacology (Berl). 2009 Mar;203(1):13-22
references: 18946663
references: Psychopharmacology (Berl). 2005 Oct;181(4):781-9
references: 15983792
references: Psychopharmacology (Berl). 2002 Oct;163(3-4):319-26
references: 12373433
references: Behav Pharmacol. 2000 Feb;11(1):87-91
references: 10821213
references: Life Sci. 1994;55(3):179-87
references: 8007760
references: J Appl Behav Anal. 1996 Winter;29(4):495-504; quiz 504-5
references: 8995832
references: Drug Alcohol Depend. 2000 Feb 1;58(1-2):103-9
references: 10669060
references: Nicotine Tob Res. 2011 Jan;13(1):29-33
references: 21059817
references: J Exp Anal Behav. 1985 Jan;43(1):131-44
references: 3981084
references: Psychopharmacology (Berl). 1991;105(2):169-74
references: 1796123
references: Tob Control. 1998 Spring;7(1):92-3
references: 9706762
references: Psychopharmacology (Berl). 2000 Dec;153(1):85-92
references: 11255931
references: Eur J Pharmacol. 1998 Mar 12;345(1):13-26
references: 9593589
references: Psychiatry Res. 2006 Sep 30;144(1):91-3
references: 16905197
references: J Appl Behav Anal. 1991 Winter;24(4):657-65
references: 1797769
references: Neuropsychopharmacology. 2003 May;28(5):919-31
references: 12637948
references: Neuropsychopharmacology. 2008 Aug;33(9):2272-82
references: 17971831
references: Psychopharmacology (Berl). 2007 Mar;190(4):485-96
references: 17205320
references: Pharmacol Biochem Behav. 2010 Apr;95(2):187-91
references: 20109483